Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naphthoquine + azithromycin monthly malaria prevention dose-ranging trial
ChiCTR1800020140Phase 2Completed
- Sponsor
- Yunnan Institute of Parasitic Diseases
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of naphthoquine and azithromycin in malaria (3 arms), sponsored by Yunnan Institute of Parasitic Diseases. Primary endpoint: Protection rate. Started Oct 2009; status: completed.
02
Drugs
naphthoquineazithromycin
03
Conditions
malaria
Beyond the preview
Go deeper on ChiCTR1800020140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020140.